OSE Immunotherapeutics Announces Granting of First European Patent Protecting Anti-IL-7 Receptor Antagonist OSE-127/S95011

NEXT STORY
Vaxil Provides Strategy Update From Conclusion of COVID-19 Challenge Study
PREV STORY
Molecular Diagnostics Devices And Equipment Market Faces Great Demand Due To Increased Testing During The COVID-19 Pandemic
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call During the American Society of Nephrology (ASN) Kidney Week 2020 Reimagined

author_avatar
NASDAQ Market News

SOM Biotech signs letter of intent with Megapharm to commercialize SOM3355 in Israel and the Palestinian Authority

author_avatar
NASDAQ Market News

Cell-Based Assays Market Size To Reach USD 28.2 Billion In 2028; CAGR of 8.5%: Reports And Data

author_avatar
NASDAQ Market News